Confirmation

EP3957752

TREATMENT AND INHIBITION OF INFLAMMATORY LUNG DISEASES IN PATIENTS HAVING RISK ALLELES IN THE GENES ENCODING IL33 AND IL1RL1

  • :
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • :
    20.3.2018
  • :
    20.8.2025
  • :
    21162316.0
  • :
    19.3.2038
  • :
    19.3.2026
  • :
    TREATMENT AND INHIBITION OF INFLAMMATORY LUNG DISEASES IN PATIENTS HAVING RISK ALLELES IN THE GENES ENCODING IL33 AND IL1RL1

20.3.2018
20.8.2025
19.3.2026
  • :
    Regeneron Pharmaceuticals, Inc.
  • :
    777 Old Saw Mill River Road, Tarrytown, NY 10591, US
  • :
    BRUSE, Shannon
  • :
    Tarrytown, New York 10591, US
  • :
    MCCARTHY, Shane
  • :
    Tarrytown, New York 10591, US
  • :
    BARAS, Aris
  • :
    Tarrytown, New York 10591, US
  • :
    DEWEY, Frederick
  • :
    Tarrytown, New York 10591, US
  • :
    GOTTESMAN, Omri
  • :
    Tarrytown, New York 10591, US
  • :
    201762485077 P
  • :
    13.4.2017
  • :
    US
  • :
    C12Q 1/6883